S&P 500   3,841.94 (+1.95%)
DOW   31,496.30 (+1.85%)
QQQ   308.68 (+1.51%)
AAPL   121.42 (+1.07%)
MSFT   231.60 (+2.15%)
FB   264.28 (+2.58%)
GOOGL   2,097.07 (+3.10%)
TSLA   597.95 (-3.78%)
AMZN   3,000.46 (+0.77%)
NVDA   498.46 (+0.74%)
BABA   233.89 (+1.47%)
CGC   31.17 (+0.52%)
GE   13.60 (+0.29%)
MU   88.93 (+5.45%)
NIO   38.11 (-2.98%)
AMD   78.52 (+0.99%)
T   29.62 (+2.42%)
F   12.27 (+2.85%)
ACB   9.60 (-2.24%)
DIS   189.99 (+1.04%)
BA   223.22 (-0.66%)
NFLX   516.39 (+1.00%)
BAC   36.93 (+1.18%)
S&P 500   3,841.94 (+1.95%)
DOW   31,496.30 (+1.85%)
QQQ   308.68 (+1.51%)
AAPL   121.42 (+1.07%)
MSFT   231.60 (+2.15%)
FB   264.28 (+2.58%)
GOOGL   2,097.07 (+3.10%)
TSLA   597.95 (-3.78%)
AMZN   3,000.46 (+0.77%)
NVDA   498.46 (+0.74%)
BABA   233.89 (+1.47%)
CGC   31.17 (+0.52%)
GE   13.60 (+0.29%)
MU   88.93 (+5.45%)
NIO   38.11 (-2.98%)
AMD   78.52 (+0.99%)
T   29.62 (+2.42%)
F   12.27 (+2.85%)
ACB   9.60 (-2.24%)
DIS   189.99 (+1.04%)
BA   223.22 (-0.66%)
NFLX   516.39 (+1.00%)
BAC   36.93 (+1.18%)
S&P 500   3,841.94 (+1.95%)
DOW   31,496.30 (+1.85%)
QQQ   308.68 (+1.51%)
AAPL   121.42 (+1.07%)
MSFT   231.60 (+2.15%)
FB   264.28 (+2.58%)
GOOGL   2,097.07 (+3.10%)
TSLA   597.95 (-3.78%)
AMZN   3,000.46 (+0.77%)
NVDA   498.46 (+0.74%)
BABA   233.89 (+1.47%)
CGC   31.17 (+0.52%)
GE   13.60 (+0.29%)
MU   88.93 (+5.45%)
NIO   38.11 (-2.98%)
AMD   78.52 (+0.99%)
T   29.62 (+2.42%)
F   12.27 (+2.85%)
ACB   9.60 (-2.24%)
DIS   189.99 (+1.04%)
BA   223.22 (-0.66%)
NFLX   516.39 (+1.00%)
BAC   36.93 (+1.18%)
S&P 500   3,841.94 (+1.95%)
DOW   31,496.30 (+1.85%)
QQQ   308.68 (+1.51%)
AAPL   121.42 (+1.07%)
MSFT   231.60 (+2.15%)
FB   264.28 (+2.58%)
GOOGL   2,097.07 (+3.10%)
TSLA   597.95 (-3.78%)
AMZN   3,000.46 (+0.77%)
NVDA   498.46 (+0.74%)
BABA   233.89 (+1.47%)
CGC   31.17 (+0.52%)
GE   13.60 (+0.29%)
MU   88.93 (+5.45%)
NIO   38.11 (-2.98%)
AMD   78.52 (+0.99%)
T   29.62 (+2.42%)
F   12.27 (+2.85%)
ACB   9.60 (-2.24%)
DIS   189.99 (+1.04%)
BA   223.22 (-0.66%)
NFLX   516.39 (+1.00%)
BAC   36.93 (+1.18%)
Log in
NYSE:OSH

Oak Street Health Stock Forecast, Price & News

$52.41
+3.45 (+7.05 %)
(As of 03/5/2021 12:00 AM ET)
Add
Compare
Today's Range
$44.12
Now: $52.41
$52.68
50-Day Range
$48.96
MA: $55.85
$64.99
52-Week Range
$37.11
Now: $52.41
$66.31
Volume2.07 million shs
Average Volume939,854 shs
Market Capitalization$12.62 billion
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Oak Street Health, Inc., through its subsidiaries, offers healthcare services to the patients in the United States. The company operates primary care centers for Medicare beneficiaries. As of September 30, 2020, it operated 67 centers in Illinois, Indiana, Michigan, North Carolina, Ohio, Pennsylvania, Rhode Island, Tennessee, and Texas. The company was founded in 2012 and is headquartered in Chicago, Illinois.
Oak Street Health logo

Headlines

Oak Street Health Reaches Analyst Target Price
February 12, 2021 |  nasdaq.com
Oak Street Health Inc.
February 6, 2021 |  barrons.com
Is OSH A Good Stock To Buy?
December 19, 2020 |  finance.yahoo.com
Oak Street Health initiates secondary equity offering
November 30, 2020 |  seekingalpha.com
Goldman Sachs: These 3 Stocks Could Spike Over 40%
November 27, 2020 |  finance.yahoo.com
See More Headlines

Industry, Sector and Symbol

Industry Health services
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone312-733-9730
Employees2,300
Year FoundedN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Market Cap$12.62 billion
Next Earnings Date3/9/2021 (Confirmed)
OptionableNot Optionable

MarketRank

Overall MarketRank

2.11 out of 5 stars

Medical Sector

44th out of 1,972 stocks

Health Services Industry

1st out of 10 stocks

Analyst Opinion: 4.5Community Rank: 3.8Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 0.6 5 -4 -3 -2 -1 -
$52.41
+3.45 (+7.05 %)
(As of 03/5/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive OSH News and Ratings via Email

Sign-up to receive the latest news and ratings for OSH and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Oak Street Health (NYSE:OSH) Frequently Asked Questions

Is Oak Street Health a buy right now?

12 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Oak Street Health in the last year. There are currently 1 hold rating and 11 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Oak Street Health stock.
View analyst ratings for Oak Street Health
or view top-rated stocks.

What stocks does MarketBeat like better than Oak Street Health?

Wall Street analysts have given Oak Street Health a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Oak Street Health wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is Oak Street Health's next earnings date?

Oak Street Health is scheduled to release its next quarterly earnings announcement on Tuesday, March 9th 2021.
View our earnings forecast for Oak Street Health
.

How can I listen to Oak Street Health's earnings call?

Oak Street Health will be holding an earnings conference call on Tuesday, March 9th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

How were Oak Street Health's earnings last quarter?

Oak Street Health, Inc. (NYSE:OSH) issued its quarterly earnings results on Monday, November, 9th. The company reported ($0.15) earnings per share (EPS) for the quarter, meeting analysts' consensus estimates of ($0.15). The business had revenue of $217.90 million for the quarter, compared to analysts' expectations of $213 million. The company's revenue for the quarter was up 56.6% on a year-over-year basis.
View Oak Street Health's earnings history
.

What price target have analysts set for OSH?

12 analysts have issued 12-month price objectives for Oak Street Health's stock. Their forecasts range from $52.00 to $78.00. On average, they anticipate Oak Street Health's stock price to reach $66.40 in the next year. This suggests a possible upside of 26.7% from the stock's current price.
View analysts' price targets for Oak Street Health
or view top-rated stocks among Wall Street analysts.

Who are Oak Street Health's key executives?

Oak Street Health's management team includes the following people:
  • Mr. Michael T. Pykosz, Chairman & CEO (Age 39, Pay $983.42k)
  • Mr. Geoffrey M. Price, COO & Director (Age 39, Pay $895.2k)
  • Dr. Griffin R. Myers, Chief Medical Officer & Director (Age 40, Pay $735.81k)
  • Mr. Brian Clem, Pres (Age 39)
  • Mr. Timothy M. Cook, Chief Financial Officer
  • Mr. Jason Van den Eeden, Chief Technology Officer
  • Mr. Robert Guenthner, Chief Legal Officer (Age 49)
  • Ms. Cynthia Hiskes, Chief HR Officer (Age 52)
  • Mr. James J. Chow, Pres of Managed Care Operations (Age 54)
  • Dr. Rafe Petty, Division Pres of IN/MI/NC/OH

What is Peter Botten's approval rating as Oak Street Health's CEO?

17 employees have rated Oak Street Health CEO Peter Botten on Glassdoor.com. Peter Botten has an approval rating of 71% among Oak Street Health's employees.

Who are some of Oak Street Health's key competitors?

What other stocks do shareholders of Oak Street Health own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Oak Street Health investors own include Alibaba Group (BABA), Tesla (TSLA), Adobe (ADBE), NVIDIA (NVDA), Okta (OKTA), Zoom Video Communications (ZM), Autodesk (ADSK), The Boeing (BA), Lockheed Martin (LMT) and Micron Technology (MU).

When did Oak Street Health IPO?

(OSH) raised $250 million in an initial public offering (IPO) on Thursday, August 6th 2020. The company issued 15,600,000 shares at a price of $15.00-$17.00 per share. J.P. Morgan, Goldman Sachs and Morgan Stanley served as the underwriters for the IPO and William Blair, Piper Sandler, Baird and SunTrust Robinson Humphrey were co-managers.

What is Oak Street Health's stock symbol?

Oak Street Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "OSH."

When did the company's lock-up period expire?

Oak Street Health's lock-up period expired on Tuesday, February 2nd. Oak Street Health had issued 15,625,000 shares in its initial public offering on August 6th. The total size of the offering was $328,125,000 based on an initial share price of $21.00. Shares of the company owned by major shareholders and company insiders are now eligible to be traded as a result of the expiration of the lock-up period.

Who are Oak Street Health's major shareholders?

Oak Street Health's stock is owned by many different institutional and retail investors. Top institutional investors include BlackRock Inc. (1.59%), Price T Rowe Associates Inc. MD (0.61%), Wells Fargo & Company MN (0.37%), Brown Advisory Inc. (0.33%), Bloom Tree Partners LLC (0.30%) and JPMorgan Chase & Co. (0.23%). Company insiders that own Oak Street Health stock include General Atlantic Llc, Geoffrey M Price, Griffin Myers, Kim Keck, Michael T Pykosz, Robert Guenthner and Timothy M Cook.
View institutional ownership trends for Oak Street Health
.

Which major investors are selling Oak Street Health stock?

OSH stock was sold by a variety of institutional investors in the last quarter, including Bloom Tree Partners LLC, Healthcare of Ontario Pension Plan Trust Fund, Healthcare of Ontario Pension Plan Trust Fund, Inherent Group LP, Russell Investments Group Ltd., Squarepoint Ops LLC, Calamos Advisors LLC, and Next Century Growth Investors LLC. Company insiders that have sold Oak Street Health company stock in the last year include General Atlantic Llc, Geoffrey M Price, Griffin Myers, Michael T Pykosz, Robert Guenthner, and Timothy M Cook.
View insider buying and selling activity for Oak Street Health
or view top insider-selling stocks.

Which major investors are buying Oak Street Health stock?

OSH stock was purchased by a variety of institutional investors in the last quarter, including Wells Fargo & Company MN, Nuveen Asset Management LLC, BlackRock Inc., Brown Advisory Inc., Orbimed Advisors LLC, Monashee Investment Management LLC, PFM Health Sciences LP, and Schroder Investment Management Group.
View insider buying and selling activity for Oak Street Health
or or view top insider-buying stocks.

How do I buy shares of Oak Street Health?

Shares of OSH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Oak Street Health's stock price today?

One share of OSH stock can currently be purchased for approximately $52.41.

How much money does Oak Street Health make?

Oak Street Health has a market capitalization of $12.62 billion.

How many employees does Oak Street Health have?

Oak Street Health employs 2,300 workers across the globe.

What is Oak Street Health's official website?

The official website for Oak Street Health is www.oakstreethealth.com.

Where are Oak Street Health's headquarters?

Oak Street Health is headquartered at 30 W. MONROE ST. STE. 1200, CHICAGO IL, 60603.

How can I contact Oak Street Health?

Oak Street Health's mailing address is 30 W. MONROE ST. STE. 1200, CHICAGO IL, 60603. The company can be reached via phone at 312-733-9730 or via email at [email protected]


This page was last updated on 3/5/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.